Article
One-year pilot study on the effects of nitisinone on melanin in patients with OCA-1B
23 Jan 2019
Abstract excerpt
BACKGROUND: Oculocutaneous albinism (OCA) results in reduced melanin synthesis, skin hypopigmentation, increased risk of UV-induced malignancy, and developmental eye abnormalities affecting vision. No treatments exist. We have shown that oral nitisinone increases ocular and fur pigmentation in a mouse model of one form of albinism, OCA-1B, due to hypomorphic mutations in the Tyrosinase gene. METHODS: In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
